TGF Beta 2 Antibody

Product Specifications

Background

Transforming growth factor-beta 2 (TGF-?2) is a cytokine that performs many cellular functions and has a vital role during embryonic development. It is an extracellular glycosylated protein. It is known to suppress the effects of interleukin dependent T-cell tumors. There are two named isoforms of this protein, created by alternative splicing of the same gene.

NCBI Gene ID

7042

Swiss Prot

P61812

Accession Number

P61812

Host

Rabbit

Reactivity

Human

Immunogen

This TGF Beta 2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 277-306 amino acids from the C-terminal region of human TGF Beta 2.

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Cancer, Cell Cycle, Obesity, Signal Transduction

Purification

This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

Concentration

Batch dependent

Buffer

Supplied in PBS with 0.09% (W/V) sodium azide.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Calculated Molecular Weight

48 kDa

Fragment

Rabbit Ig

Symbol

TGFB2

NCBI Official Name

Transforming growth factor beta-2

NCBI Organism

Homo sapiens

Background Reference 01

Hatsushika, K., Clin. Exp. Allergy 37 (8), 1165-1174 (2007) Jimi, S., Int. J. Oncol. 31 (2), 397-404 (2007) Ito, T., Biochem. Biophys. Res. Commun. 359 (1), 108-114 (2007) Yao, K., Mol. Vis. 13, 1769-1776 (2007)

Other Product Names

Transforming growth factor beta-2, TGF-beta-2, BSC-1 cell growth inhibitor, Cetermin, Glioblastoma-derived T-cell suppressor factor, G-TSF, Polyergin, Latency-associated peptide, LAP, TGFB2